Ritu Salani, MD

Articles

Dr. Salani on the Role of Molecular Profiling in Endometrial Cancer Treatment

November 1st 2022

Ritu Salani, MD, MBA, discusses the importance of histological subtyping and molecular profiling in developing treatment strategies and improving outcomes for patients with endometrial cancer.

Dr. Salani on Future Research Opportunities in Recurrent Ovarian Cancer

October 29th 2021

Ritu Salani, MD, MBA, discusses future research opportunities for improving the treatment of patients with recurrent ovarian cancer.

Dr. Salani on the Rationale for Immunotherapy/PARP Inhibitor Combos in Ovarian Cancer

October 4th 2021

Ritu Salani, MD, MBA, discusses the rationale for combinations of immunotherapy and PARP inhibitors in ovarian cancer.

Dr. Salani on the Potential Impact of Ongoing Research in Ovarian Cancer

September 22nd 2021

Ritu Salani, MD, MBA, discusses the scope of ongoing research in advanced ovarian cancer.

Dr. Salani on Therapeutic Advances in Endometrial Cancer

November 2nd 2020

Ritu Salani, MD, MBA, discusses therapeutic advances in endometrial cancer.

Dr. Salani on the Current State of Biomarker Testing in Cervical Cancer

July 8th 2020

Ritu Salani, MD, MBA, discusses the current state of biomarker testing in cervical cancer.

Dr. Salani on Opportunities for Precision Medicine in Cervical Cancer

June 11th 2020

Ritu Salani, MD, discusses opportunities for precision medicine in cervical cancer.

Dr. Salani on Opportunities for Precision Medicine in Cervical Cancer

June 10th 2020

Ritu Salani, MD, discusses opportunities for precision medicine in cervical cancer.

Dr. Salani on Choosing Among IV, IP, and Dose-Dense Chemo Regimens in Ovarian Cancer

March 26th 2020

Ritu Salani, MD, provides insight into how to approach selection of chemotherapy in ovarian cancer.

Dr. Salani on the Progression of Upfront Ovarian Cancer Treatment

March 7th 2020

Ritu Salani, MD, discusses the progression of upfront ovarian cancer treatment.

Dr. Salani on Patient Selection for Primary Debulking Surgery in Ovarian Cancer

January 25th 2020

Ritu Salani, MD, discusses selecting patients with ovarian cancer for primary debulking surgery versus neoadjuvant chemotherapy.

Dr. Salani Discusses Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in Ovarian Cancer

November 22nd 2019

Ritu Salani, MD, discusses considerations for neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.

Dr. Salani Discusses Potential Treatment Modalities in Cervical Cancer

November 21st 2019

Ritu Salani, MD, discusses the potential of targeted therapy and immunotherapy in cervical cancer.